The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.EBI
Xenon Pharmaceuticals
Endothelial lipase inhibitors for the treatment of atherosclerosis and cardiovascular disorders.EBI
Therachem Research Medilab (India)
A thiocarbamate inhibitor of endothelial lipase raises HDL cholesterol levels in mice.EBI
Janssen Research and Development
Design and synthesis of boronic acid inhibitors of endothelial lipase.EBI
Tufts University School of Medicine
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors.EBI
Glaxosmithkline
Benzothiazole-based compounds as potent endothelial lipase inhibitors.EBI
Bristol-Myers Squibb
Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase.EBI
Bristol-Myers Squibb
Sulfonylated Benzothiazoles as Inhibitors of Endothelial Lipase.EBI
Bristol-Myers Squibb
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitors.EBI
Bristol-Myers Squibb
Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) That Demonstrate HDL-C Increase In Vivo.EBI
TBA
Benzopyrroloxazines containing a bridgehead nitrogen atom as promising scaffolds for the achievement of biologically active agents.EBI
University of Calabria
PK/PD Disconnect Observed with a Reversible Endothelial Lipase Inhibitor.EBI
Bristol-Myers Squibb
Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.BDB
University of Waterloo
Organic compoundsBDB
Novartis
Structure and function of PA4872 from Pseudomonas aeruginosa, a novel class of oxaloacetate decarboxylase from the PEP mutase/isocitrate lyase superfamily.BDB
University of Maryland Biotechnology Institute
Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode.BDB
The University of Kansas
Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.BDB
Cornell University
8-Carboxamidocyclazocine: a long-acting, novel benzomorphan.BDB
University of Rochester
A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides.BDB
University of Toronto
Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.BDB
University of Cincinnati
Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family.BDB
Novo Nordisk
Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line.BDB
University of Missouri
Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.BDB
Lundbeck Ais